These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 23522028

  • 1. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
    Jansen A, Szekat C, Schröder W, Wolz C, Goerke C, Lee JC, Türck M, Bierbaum G.
    BMC Microbiol; 2013 Mar 22; 13():65. PubMed ID: 23522028
    [Abstract] [Full Text] [Related]

  • 2. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
    Reipert A, Ehlert K, Kast T, Bierbaum G.
    Antimicrob Agents Chemother; 2003 Feb 22; 47(2):568-76. PubMed ID: 12543661
    [Abstract] [Full Text] [Related]

  • 3. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.
    Jansen A, Türck M, Szekat C, Nagel M, Clever I, Bierbaum G.
    Int J Med Microbiol; 2007 Jul 22; 297(4):205-15. PubMed ID: 17418637
    [Abstract] [Full Text] [Related]

  • 4. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K.
    Antimicrob Agents Chemother; 2016 Jun 22; 60(6):3730-42. PubMed ID: 27067329
    [Abstract] [Full Text] [Related]

  • 5. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
    G C B, Sahukhal GS, Elasri MO.
    Antimicrob Agents Chemother; 2019 Oct 22; 63(10):. PubMed ID: 31307991
    [Abstract] [Full Text] [Related]

  • 6. Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes.
    Malachowa N, Sturdevant DE, Porter AR, Martin G, Martens C, Nair V, Hansen B, Ricklefs S, Jenkins SG, Chen L, Kreiswirth BN, DeLeo FR.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0048624. PubMed ID: 38916317
    [Abstract] [Full Text] [Related]

  • 7. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0052821. PubMed ID: 34668723
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M, Cui L, Kim J, Hiramatsu K.
    Antimicrob Agents Chemother; 2013 Dec 31; 57(12):5843-53. PubMed ID: 24018261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K.
    Antimicrob Agents Chemother; 2011 Aug 31; 55(8):3870-81. PubMed ID: 21628539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
    Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH.
    J Clin Microbiol; 2002 Apr 31; 40(4):1376-80. PubMed ID: 11923359
    [Abstract] [Full Text] [Related]

  • 17. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.
    Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H.
    PLoS One; 2013 Apr 31; 8(9):e73300. PubMed ID: 24069184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate.
    Baseri N, Najar-Peerayeh S, Bakhshi B, Campanile F.
    BMC Microbiol; 2022 Apr 13; 22(1):100. PubMed ID: 35418037
    [Abstract] [Full Text] [Related]

  • 20. Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus.
    Tan XE, Neoh HM, Looi ML, Chin SF, Cui L, Hiramatsu K, Hussin S, Jamal R.
    Can J Microbiol; 2017 Mar 13; 63(3):260-264. PubMed ID: 28059579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.